Tianjin Tianyao Pharmaceuticals Co Ltd

SHG:600488 China Drug Manufacturers - Specialty & Generic
Market Cap
$628.00 Million
CN¥4.61 Billion CNY
Market Cap Rank
#13353 Global
#3413 in China
Share Price
CN¥4.22
Change (1 day)
+0.72%
52-Week Range
CN¥3.84 - CN¥4.66
All Time High
CN¥7.14
About

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid r… Read more

Tianjin Tianyao Pharmaceuticals Co Ltd (600488) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.003x

Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.19 Million) by net assets (CN¥3.89 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tianjin Tianyao Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Tianyao Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.89 Billion CN¥569.37 Million 0.147x -29.76%
2023-12-31 CN¥3.75 Billion CN¥783.01 Million 0.209x +19.83%
2022-12-31 CN¥3.75 Billion CN¥653.52 Million 0.174x +109.69%
2021-12-31 CN¥3.82 Billion CN¥316.89 Million 0.083x -9.71%
2020-12-31 CN¥3.77 Billion CN¥346.88 Million 0.092x +18.02%
2019-12-31 CN¥3.59 Billion CN¥279.37 Million 0.078x +35.10%
2018-12-31 CN¥3.28 Billion CN¥189.27 Million 0.058x +2315.44%
2017-12-31 CN¥3.13 Billion CN¥-8.15 Million -0.003x -110.24%
2016-12-31 CN¥2.49 Billion CN¥63.32 Million 0.025x -51.92%
2015-12-31 CN¥2.45 Billion CN¥129.50 Million 0.053x -29.13%
2014-12-31 CN¥2.40 Billion CN¥178.76 Million 0.075x +105.28%
2013-12-31 CN¥2.33 Billion CN¥84.55 Million 0.036x +385.84%
2012-12-31 CN¥1.77 Billion CN¥13.23 Million 0.007x -83.92%
2011-12-31 CN¥1.69 Billion CN¥78.47 Million 0.047x -35.03%
2010-12-31 CN¥1.63 Billion CN¥116.82 Million 0.072x -74.40%
2009-12-31 CN¥1.56 Billion CN¥435.13 Million 0.280x +91.77%
2008-12-31 CN¥1.50 Billion CN¥219.31 Million 0.146x +31.22%
2007-12-31 CN¥1.46 Billion CN¥162.33 Million 0.111x +136.07%
2006-12-31 CN¥1.08 Billion CN¥50.72 Million 0.047x +145.17%
2005-12-31 CN¥1.04 Billion CN¥-108.87 Million -0.104x -193.30%
2004-12-31 CN¥987.47 Million CN¥110.30 Million 0.112x +128.34%
2003-12-31 CN¥935.65 Million CN¥45.77 Million 0.049x -15.24%
2002-12-31 CN¥784.51 Million CN¥45.28 Million 0.058x -42.62%
2001-12-31 CN¥714.63 Million CN¥71.87 Million 0.101x -48.14%
2000-12-31 CN¥211.75 Million CN¥41.06 Million 0.194x --